Skip to main content

Supernus Pharmaceuticals to acquire Biscayne Neurotherapeutics for up to $185M – Washington Business Journal

By September 17, 2018News
supernus-pharmaceuticals-logo

supernus-pharmaceuticals-logo

Rockville-based Supernus Pharmaceuticals Inc. has reached a deal to acquire Miami-based Biscayne Neurotherapeutics in a deal worth up to $185 million.

{iframe}https://www.bizjournals.com/washington/news/2018/09/14/supernus-pharmaceuticals-to-acquire-miami-biotech.html{/iframe}

Leave a Reply

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.